Takeda Pharmaceutical Company Limited Earnings

Takeda Pharmaceutical Company Limited’s revenue fell -5.38% since last year same period to $1112796Mn in the Q3 2025. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 0.55% jump in its revenue since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit fell -112.82% since last year same period to $-11802Mn in the Q3 2025. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -109.5% fall in its net profits since last 3-months.

Takeda Pharmaceutical Company Limited’s net profit margin fell -113.55% since last year same period to -1.06% in the Q3 2025. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -109.45% fall in its net profit margins since last 3-months.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.15 - a -24.73% fall from last quarter’s estimates.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.15.

Takeda Pharmaceutical Company Limited’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Takeda Pharmaceutical Company Limited has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.